Nexium esomeprazole delayed-release oral suspension regulatory update

FDA approved an NDA from AstraZenexa for 10 mg Nexium esomeprazole delayed-release oral suspension to treat gastroesophageal reflux disease (GERD) in children aged 1-11 years. The proton pump inhibito...